Age as a modifying factor on the effect of antihypertensive therapy in focal stroke in rats.
Author(s) -
Andrew Slivka
Publication year - 1993
Publication title -
stroke
Language(s) - English
Resource type - Journals
SCImago Journal Rank - 3.397
H-Index - 319
eISSN - 1524-4628
pISSN - 0039-2499
DOI - 10.1161/01.str.24.2.241
Subject(s) - medicine , hydralazine , ischemia , stroke (engine) , blood pressure , spontaneously hypertensive rat , middle cerebral artery , cardiology , common carotid artery , anesthesia , carotid arteries , mechanical engineering , engineering
Antihypertensive treatment with hydralazine for 10 weeks but not 6 weeks reduces infarct size in 13-week-old spontaneously hypertensive rats subjected to focal cerebral ischemia. This study was designed to examine whether the duration of treatment needed to reduce infarct size depends on how long hypertension is present before the initiation of antihypertensive therapy.
Accelerating Research
Robert Robinson Avenue,
Oxford Science Park, Oxford
OX4 4GP, United Kingdom
Address
John Eccles HouseRobert Robinson Avenue,
Oxford Science Park, Oxford
OX4 4GP, United Kingdom